USPTO trademark

SISAQOL

Opposition periodUSPTOWord markClass 41Class 42Class 44

"SISAQOL" is a word mark owned by Organisation Europeenne Pour la Recherche et le Traitement du Cancer - European Organisation for Research and Treatment of Cancer, In Short Eortc, filed at the USPTO on December 22, 2025. It is in its opposition period and covers classes 41, 42 and 44.

Get this data via the API
Official USPTO record
SISAQOL trademark as filed
As filed with the USPTO
Status
Opposition period
Since September 22, 2026
Filed
December 22, 2025
Registered
Not yet
Priority date
July 29, 2025
Claimed from European Union
Application no.
99560444
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns SISAQOL

The owner and representative on file with the office.

Owner

Organisation Europeenne Pour la Recherche et le Traitement du Cancer - European Organisation for Research and Treatment of Cancer, In Short Eortc

Brussels, Belgium

Representative

Martin W. Schiffmiller

Kirschstein Israel Schiffmiller & Pieroni, P.C.

Goods and services

What the mark covers

The products and services SISAQOL is filed for, grouped by Nice class.

  • Arranging of educational conferences, workshops and training sessions in the fields of patient-reported outcomes (PROs) and health-related quality of life (HRQOL); providing online non-downloadable electronic publications in the form of books, journals, articles, reports, educational materials, transcripts and graphs in the fields of patient-reported outcomes (PROs) and health-related quality of life (HRQOL); providing training in the fields of reporting of outcomes in clinical research and healthcare practice, and in the fields of methodology and implementation of patient-reported outcomes (PROs) relating to the reporting of outcomes in clinical research and healthcare practice; providing recommendations on literature relating to the reporting of outcomes in clinical research and healthcare practice, and in the fields of methodology and implementation of patient-reported outcomes (PROs) relating to the reporting of outcomes in clinical research and healthcare practice

  • Scientific and technological services, namely, the development and testing of methodologies for the design, analysis, interpretation, and presentation of patient-reported outcomes (PROs) in clinical trials or other medical research; Research and design of standardized data analysis frameworks in oncology and other therapeutic areas; Providing scientific information, clinical research support advice and consultancy relating to patient-reported outcomes (PROs) and health-related quality of life (HRQOL); Development of software tools for the implementation of patient-reported outcomes (PROs) in health-related research; hosting and maintenance of online platforms and non-downloadable software for others in the field of patient-reported outcomes (PROs) methodology implementation

  • Medical consultancy and advisory services relating to patient-reported outcomes (PROs), including their use in clinical practice and treatment evaluation; Providing medical information related to PROs; Providing medical information and guidance to healthcare professionals on interpreting and applying patient-reported outcomes (PROs) data in oncology and other therapeutic areas; Medical consultancy in the field of patient-centered care and medical outcomes assessment; Medical consultancy relating to the support of personalized treatment planning through the structured use of patient-reported outcomes (PROs) frameworks

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Official gazette publication confirmation e-mailed
  2. Published for opposition
  3. Notification of notice of publication e-mailed
  4. Approved for pub - principal register
  5. Notification of examiners amendment e-mailed
  6. Examiner's amendment entered
  7. Examiners amendment e-mailed
  8. Examiners amendment -written
  9. Teas/email correspondence entered
  10. Correspondence received in law office

10 earlier steps on the official record.

FAQ

About SISAQOL

Who owns the trademark "SISAQOL"?

The USPTO trademark "SISAQOL" (application 99560444) is owned by Organisation Europeenne Pour la Recherche et le Traitement du Cancer - European Organisation for Research and Treatment of Cancer, In Short Eortc.

What is the status of "SISAQOL"?

Its status at the USPTO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull SISAQOL and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b7a-c5fd-7509-a6c0-15e5cd2045a8
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b7a-c5fd-7509-a6c0-15e5cd2045a8",
  "object": "trademark",
  "mark_text": "SISAQOL",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "US",
  "application_number": "99560444",
  "filing_date": "2025-12-22",
  "nice_classes": [
    41,
    42,
    44
  ],
  "owners": [
    {
      "name": "ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER, in short EORTC",
      "entity_id": null
    }
  ]
}